| mRNA |
Pyrimethamine |
GDSC1000 |
pan-cancer |
AAC |
-0.0072 |
0.9 |
| mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0051 |
0.9 |
| mRNA |
prima-1 |
CTRPv2 |
pan-cancer |
AAC |
0.0044 |
0.9 |
| mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
-0.0044 |
0.9 |
| mRNA |
ABT-263 |
FIMM |
pan-cancer |
AAC |
0.018 |
0.9 |
| mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0044 |
0.9 |
| mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0045 |
0.9 |
| mRNA |
Pazopanib |
FIMM |
pan-cancer |
AAC |
0.021 |
0.9 |
| mRNA |
AZ-3146 |
CTRPv2 |
pan-cancer |
AAC |
-0.0045 |
0.9 |
| mRNA |
ML312 |
CTRPv2 |
pan-cancer |
AAC |
0.0086 |
0.9 |